Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Multiple Sclerosis × Alemtuzumab × Clear all

Sponsor

Conditions

Leukemia 33 Leukemia, Lymphocytic, Chronic, B-Cell 26 Lymphoma 19 Myelodysplastic Syndromes 16 Hodgkin Disease 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Multiple Myeloma 10 Leukemia, Myeloid, Acute 10 Lymphoma, Non-Hodgkin 8 Lymphoma, Mantle-Cell 7 Lymphoma, Follicular 7 Recurrence 6 Myeloproliferative Disorders 6 Lymphoma, Large B-Cell, Diffuse 6 Leukemia, Myeloid, Chronic-Phase 6 Lymphoma, B-Cell, Marginal Zone 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Hematologic Neoplasms 5 Waldenstrom Macroglobulinemia 4 Neoplasms, Plasma Cell 4 Lymphoma, T-Cell, Cutaneous 4 Congenital Abnormalities 4 Burkitt Lymphoma 4 Anemia, Aplastic 4 Sezary Syndrome 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Myelodysplastic-Myeloproliferative Diseases 3 Mycosis Fungoides 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, Large-Cell, Immunoblastic 3

Interventions

Natalizumab 1 Magnetic Resonance Imaging 1 Interferon beta-1a 1 Fish Oils 1 Fingolimod Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡